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Abstract
Background: Using outcome measures to advance healthcare continues to be of widespread interest. The goal is
to summarize the results of studies which use outcome measures from clinical registries to implement and monitor
QI initiatives. The second objective is to identify a) facilitators and/or barriers that contribute to the realization of QI
efforts, and b) how outcomes are being used as a catalyst to change outcomes over time.
Methods: We searched the PubMed, EMBASE and Cochrane databases for relevant articles published between
January 1995 and March 2017. We used a standardized data abstraction form. Studies were included when the
following three criteria were fulfilled: 1) they relied on structural data collection, 2) when a structural and
comprehensive QI intervention had been implemented and evaluated, and 3) impact on improving clinical and/or
patient-reported outcomes was described. Data on QI strategies, QI initiatives and the impact on outcomes was
extracted using standardized assessment tools.
Results: We included 21 articles, of which eight showed statistically significant improvements on outcomes using
data from clinical registries. Out of these eight studies, the Chronic Care Model, IT application as feedback,
benchmarking and the Collaborative Care Model were used as QI methods. Encouraging trends in realizing
improved outcomes through QI initiatives were observed, ranging from improving teamwork, implementation of
clinical guidelines, implementation of physician alerts and development of a decision support system. Facilitators
for implementing QI initiatives included a high quality database, audits, frequent reporting and feedback, patient
involvement, communication, standardization, engagement, and leadership.
Conclusion: This review suggests that outcomes collected in clinical registries are supportive to realize QI initiatives.
Organizational readiness and an active approach are key in achieving improved outcomes.
Keywords: Clinical registries, Quality improvement, Value-based healthcare, Improvement science
Background
The use of clinical registries is considered crucial to sys-
tematically measure clinical outcomes in achieving bet-
ter value for patients [1]. A clinical or patient registry is
defined as “an organized system that uses observational
study methods to collect uniform data (clinical data as
structure, process and outcome measures) to evaluate
specified outcomes for a population defined by a par-
ticular disease, condition, or exposure” [2]. Registries
that are used for evaluating patient outcomes are used
for the purpose of this review. The importance of clinical
registries has been widely recognized as a tool to realize
quality improvement (QI) and public accountability [1,
3–8]. Medical associations use clinical registries for
collecting data using pre-defined measures in patients
undergoing a certain procedure or for a specific disease
[9]. In particular, feedback based on clinical registry data
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is used to identify and monitor improvement initiatives
[10]. Therefore, registries are seen as a promising tool to
achieve improvements in value for the patient by meas-
uring outcomes [1]. A previous review on the structure,
use and limitations of current clinical registries showed
that registries and their respective measures are used for
monitoring the work of health care providers, discussion
platforms for QI, improving risk adjustment modelling
and for improving preoperative risk profiling [11]. How-
ever, the current body of literature lacks insights into the
extent to which the use of outcome measures from clin-
ical registries, either when identifying, selecting or moni-
toring QI initiatives, can impact health outcomes.
With rising healthcare costs, service restrictions, dif-
ferences in quality and costs, there is an increasing need
for reform to improve value of healthcare [12]. Value in
healthcare is defined as outcomes relative to costs [13].
Value-based health care aims at achieving higher value
for patients while ensuring sustainability of the health-
care system by an efficient and effective delivery of care
[14]. This goal is assumed to be achieved by measuring
and using outcomes per medical condition for the iden-
tification of improvement potential across the full cycle
of care [12]. Higher value for patients by measuring out-
comes is one of the potential methods for improving
quality of healthcare relative to the costs spent. For the
purposes of this review, we only focused on outcome
measures and not on the respective costs.
Quality of healthcare is generally assessed by using
structure, process or outcome measures [15]. The latter
provide insights into outcomes of a certain disease or
several diseases, for instance on survival, functional sta-
tus, and quality of life [16]. The aim of measuring out-
comes is diverse; guiding clinical decision-making,
initiating improvement interventions, benchmarking,
monitoring, scientific research and public accountability.
Measuring outcomes structurally and using them to
identify possible improvements contributes to the aim of
achieving higher value for patients [17].
The goal is to summarize the results of studies which
use outcome measures from clinical registries to imple-
ment and monitor QI initiatives. For the purpose of this
study, QI was defined as the application of a defined im-
provement process to achieve measurable improvement
by implementing an improvement intervention. Registry
data itself is not sufficient as they need QI methods in
order to achieve actual improvement. The second object-
ive is to identify a) facilitators and/or barriers that contrib-
ute to the realization of QI efforts, and b) how outcomes
are being used as a catalyst to change outcomes over time.
Methods
A systematic review was conducted of studies published
between January 1995 and March 2017. The search
strategy was designed for PubMed, EMBASE and
Cochrane databases. To identify evidence for the use of
clinical registries to improve or contribute to patient
health outcomes, the following PubMed Mesh terms
were used to identify studies: mortality, patient outcome
assessment and treatment outcome. These terms were
combined with a variety of search terms related to QI
and diverse disease specific registry studies. No specific
patient group or study design was defined. Details of the
complete search strategy are provided in the online
supplementary content (Additional file 1: Appendix 1).
Additional hand-searching has been conducted for sys-
tematic reviews on the subject during the review process.
The hand-search was conducted in Google Scholar.
Inclusion and exclusion criteria
Studies were included when they met each of the follow-
ing criteria: 1) published in peer-reviewed journals, 2)
published in English, French or German, 3) the study
actively implemented a strategy using outcome data to
realize QI, 4) the study relied on structural data collec-
tion, and 5) the study evaluated the QI interventions re-
alized. Whether a study made use of a QI effort, falling
under criteria 3 and 5, was evaluated after reviewing the
full text papers and was therefore not part of the search
string. After title screening, included studies were evalu-
ated on criteria 3 and 5. Studies were excluded when
they analyzed the effect of new intervention(s) on out-
comes (testing drugs, new techniques or the effect of an
intervention) or when the data had solely been collected
to evaluate an intervention in a clinical trial.
Data extraction and quality assessment
For the initial selection each reviewer reviewed a ran-
dom set on first title, second abstract, and finally full
text to determine eligibility. The full text articles were
critically reviewed and judged by all reviewers. Any dis-
agreement between reviewers was discussed by the full
review team until consensus was achieved. The selected
articles were evaluated using a standardized predesigned
form listing whether the inclusion criteria were met.
A thorough review process was carried out for the
data quality assessment, which consisted of the following
three steps:
Step 1: Data abstraction
The Cochrane data abstraction form for intervention
reviews (RCTs and non-RCTs) was used as a tool to ex-
tract data on study design and methodological quality
(Additional file 1: Appendix 2) [18]. Furthermore, data
on the target group, main results, main outcome mea-
sures, data source, geographical setting and funding
sources was abstracted.
Step 2: Rigor of QI intervention
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The included studies were evaluated using the Quality
Improvement Minimum Quality Criteria Set (QI-MQCS)
as a critical appraisal instrument, developed by the RAND
Corporation (Additional file 1: Appendix 3) [19]. The
QI-MQCS contains 16 domains to evaluate the QI inter-
vention, resulting in a scoring system to evaluate whether
this domain was met or not. The QI-MQSC did not intro-
duce a threshold concerning acceptability of the quality of
the papers. Therefore, we agreed on the following criteria
in order to adequately interpret the QI-MQSC score. The
study was considered to be of perfect quality (> 15 items
ranked yes), good quality (> 12 items ranked yes), moder-
ate quality (> 9 items ranked yes) and insufficient quality
(≤9 items ranked yes).
Step 3: Rigor of data collection and analysis
In addition to the QI-MQCS, 13 items were added for
further evaluation. Two questions (item 2 and 18) from
the Downs & Black (1998) criteria were used to reflect
on whether the main outcomes to be measured had been
clearly described in the introduction or methods section
and whether the statistical tests used to assess the main
outcomes were appropriate [20]. In addition, three ques-
tions (item 10c, 11a and 11b) from the SQUIRE guide-
lines were used: 1) whether a method was employed for
assessing completeness and accuracy of data, 2) whether
quantitative methods were used to draw inferences from
the data and 3) whether methods were applied for
understanding variation within the data, including the
effects of time as a variable [21]. Furthermore, it was
evaluated how the included studies dealt with missing
values, whether they performed audits, reported on secu-
lar trends, performed case-mix adjustments, whether clear
inclusion and exclusion criteria had been defined for the
patient population and when possible whether a power
analysis was conducted.
In conclusion, the Cochrane data abstraction form was
used to abstract data from the selected articles in order
to identify changes in outcomes and facilitators. Data
synthesis was guided by 1) the QI-MQCS results, 2) the
merged and modified version of the Downs & Black
(1998), SQUIRE guidelines, and self-developed ques-
tions. Due to the diversity of outcomes, a pooled effect
of the results was not conducted.
Results
Search results and included studies
The final systematic search resulted in 11 524 records
for initial screening; 117 articles were included to review
the full text version of which 96 studies were excluded
because they did not meet the inclusion criteria (Fig. 1)
[22]. One additional article was included from a relevant
systematic review, which emerged from hand-searching
[23, 24]. Table 1 presents the characteristics of the 21
included studies. The studies focused on registries for
the following patient groups; patients with diabetes [24–
31], children with chronic conditions [32], patients with
lung cancer [33, 34], patients with cystic fibrosis [35–37],
patients with cardiac anomalies [38], patients undergoing
cardiac surgery [39–41], patients with acute myocardial in-
farction [42], and patients referred for home health
services [43]. The majority of the registries presented
voluntary participation [25–27, 29–31, 35, 36, 38, 40–43].
Three registries required mandatory participation [28, 33,
34]. Most of the presented registries had the purpose of
achieving QI [24, 25, 28–34, 37, 39, 41–43]. The remaining
studies have introduced their clinical registry for research
and educational purposes [26, 27, 35, 36, 38, 40, 44].
Impact of quality improvement
Eight studies showed statistically significant improve-
ment in outcomes resulting from the implementation of
QI initiatives [25, 27, 29, 31, 33, 34, 42, 44]. Statistically
significant improvements were achieved in long-term
survival [33, 34], mortality [42], readmission rate [42],
bleeding complications [42], systolic blood pressure [27],
HbA1C [27, 29], LDL [27, 29], exercise habits [25], de-
pression improved in the acute phase (PHQ-9 score)
[44], and hospitalization with ambulatory care-sensitive
conditions [31]. The remaining studies did not show sta-
tistically significant improvements. All included studies
presented outcome measures for their respective im-
provement work, five of which also measured additional
process measures [27–33, 35, 41, 42, 44]. Table 2 pre-
sents outcomes measures used, QI methods applied and
whether statistically significant improvement of outcome
measures was achieved. A detailed overview of the sig-
nificance of outcome measures can be found in the on-
line supplementary content (Additional file 1: Appendix
4). None of the studies identified an impact on patient
value or evaluated the impact on costs of care.
Quality of the studies
Rigor of quality improvement interventions
The overall quality of included articles was moderate
(see Tables 3 and 4). On the 16 domains of the
QI-MQCS four articles achieved a score of 13, which is
the highest score among included studies [24, 26, 32,
37]. These articles are therefore considered to be of good
quality. Four articles were ranked as moderate quality
with a score of 12 [35, 39, 42, 44]. Five articles scored
poorly on the QI-MQCS with a score ≤ 7, which is
ranked as low quality [31, 33, 34, 38, 41].
Rigor of data collection and analysis
The overall results of the quality assessment on data
collection and analyses are displayed in the online sup-
plementary content (Additional file 1: Appendix 5). Four
studies have applied generalized linear mixed models for
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the analysis of change in outcomes [25, 27, 36, 42]. One
study used a generalized estimating equation model with
repeated measurements [24]. Inferential statistics have
also been used in the form of survival analyses, logistic
regression and chi-square analyses [29, 31, 33, 39, 44].
The remaining studies made use of descriptive statistical
analyses only [26, 30, 32, 38, 43]. In order to monitor
change, run charts have been applied in five studies [28,
35, 37, 40, 41].
On the additional item criteria, two studies have
applied methods to account for missing values in their
data, while also conducting a power analysis [25, 27].
Methods used to achieve improvements
We identified six methods to achieve QI: benchmarking
[33, 34, 38–41], a collaborative care model [26, 28, 42,
44], Plan-Do-Check-Act [36, 37], the Chronic Care
Model [25, 32, 37], Learning and Leadership Collabora-
tive [35] and IT driven interventions [24, 27, 29, 30, 41].
There were some studies where no clear QI method was
used [29, 31, 43]. We will discuss these methods in the
following paragraphs.
Benchmarking
Benchmarking has been applied in several of the in-
cluded studies [33, 34, 38, 39, 41]. Data was mostly
compared among different hospitals [33, 34, 38]. Annual
publication of data in the form of reports has most
commonly been applied to report on results [33, 34, 41].
One study complemented their national report with
an additional disease specific report with supplemen-
tary measures [33]. Another method of benchmarking
was a discussion of the results at a (monthly or an-
nual) meeting. During the annual meeting, results
from reports were discussed and further evaluated
[38]. Also, short-term feedback cycles with monthly
publication of reports were applied [39]. The use of a
strong data-driven system in combination with audits
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Fig. 1 Flow diagram. Source: Authors’ analysis, format source from PRISMA [22]. a Exclusion criteria: 1. Studies published in peer-reviewed journals;
2. Studies published in English; 3. Did not actively implement a strategy making use of outcome data to realize quality improvement; 3. Did not
relay on structural data collection; 5. Did not evaluate quality improvement interventions using data from outcome registries
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was characteristic of initiatives that applied bench-
marking in order to improve outcomes as well as a
model to change practice [33, 34, 39, 40].
Collaborative care model
Three studies applied the Breakthrough Collaborative
Model (BCM) to structure the goal of improving
outcomes [26, 28, 42]. One study applied a Web-based
disease registry to track patients with symptoms of
depression to support treatment management in primary
care [44]. In addition, evidence-based depression man-
agement training was provided to primary care pro-
viders. Moreover, in all sites, most patients experienced
meaningful improvement in depression.
The BCM was used to design a cycle of structured dis-
cussion sessions during which outcomes were analyzed,
presented and variation in work processes were dis-
cussed [26, 28]. The model was furthermore used as a
guide to facilitate improvement efforts and insights into
data [26, 42].
Plan-do-check-act
In two studies Plan-Do-Check-Act (PDCA) cycles
were used to improve outcomes and/or processes [26,
36, 37]. Yet, the cycle was presented as a supporting
tool to other methods, either for the application of
the BCM [26] or for benchmarking [36]. For the
latter it was applied as a method to prepare for
national benchmarking by organizing three PDCA
cycles before data was shared [36]. The method was
applied by organizing multidisciplinary meetings,
where outcomes were discussed and improvement
initiatives were identified [36]. Three cycles were
organized in order to prepare public benchmarking
after the third cycle [36].
The other study, which primarily used the methods
outlined for the BCM, used the PDCA to structure
and evaluate the learning sessions [26]. However, it
was not the primary method for improving outcomes.
In another study PDCA was used to continually
evaluate local cystic fibrosis care practices, and they
were able to improve pulmonary function and nutri-
tional outcomes [37].
The chronic care model
Three studies applied the Chronic Care Model (CCM)
[25, 32, 37]. One study that applied the CCM used sup-
porting techniques such as: audit and feedback, elec-
tronic registry, clinician reminders, patient reminders,
and abbreviated patient education. It is, thus, rather a
framework offering practical tools [25]. They did not
find expected improvements in outcomes. Here, authors
suggested that another, more collaborative approach
would be needed to improve outcomes of chronic
Table 1 Characteristics of Included Studies (n = 21)
Characteristics No. (%)
Geographical setting
United States [24, 25, 27–29, 31, 32, 35, 37–41, 43, 44] 15 (71%)
Sweden [26, 42] 2 (9.5%)
Denmark [33, 34] 2 (9.5%)
Germany [36] 1 (4.8%)
Singapore [30] 1 (4.8%)
Target group
Diabetes [24–31] 8 (38.1%)
Depression [44] 1 (4.8%)
Children with chronic conditions [32] 1 (4.8%)
Lung Cancer [33, 34] 2 (9.5%)
Cystic fibrosis [35–37] 3 (14.3%)
Congenital heart disease [38] 1 (4.8%)
Myocardial infarction [42] 1 (4.8%)
Patients undergoing cardiac or cardiothoracic surgery [39–41] 3 (14.3%)
Patients referred for home health services [43] 1 (4.8%)
Study design
Observational study [29–31, 33–37, 39, 41] 10 (47.6%)
Randomized-Controlled Trial [24, 25, 27] 3 (14.3%)
Case study [26, 28] 2 (9.5%)
Cohort study [38] 1 (4.8%)
Before and after study [32, 40, 42] 3 (14.3%)
Quasi-experimental study [44] 1 (4.8%)
Prospective evaluation study [43] 1 (4.8%)
Funding sources
National funding [25, 27, 28, 31, 32, 36, 42, 43] 8 (38.1%)
Private funding [24, 29, 35, 37, 44] 5 (23.8%)
Unknown [26, 30, 33, 34, 38–41] 8 (38.1%)
Registry participation type
Voluntary [25–27, 29–31, 35, 36, 38, 40–43] 13 (62%)
Mandatory [28, 33, 34] 3 (14.3%)
Unknown [24, 32, 37, 39, 44] 5 (23.8%)
Registry purpose
Quality improvement [24, 25, 28–34, 37, 39, 41–43] 14 (66.7%)
Research and education [26, 27, 35, 36, 38, 40, 44] 7 (33.3%)
Quality improvement efforts
Benchmarking [33, 34, 38–41] 6 (28.6%)
Plan-do-check-act (PDCA) [26, 36] 2 (9.5%)
Collaborative Care Model [26, 28, 42, 44] 4 (19%)
The Chronic Care Model [25, 32] 2 (9.5%)
Learning and Leadership Collaborative [35] 1 (4.8%)
Plan-do-check-act (PDCA) and the Chronic Care Model [37] 1 (4.8%)
IT application as feedback tool [24, 27, 30, 41] 4 (19%)
No clear QI method [29, 31, 43] 3 (14.3%)
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Table 2 Improvement in outcomes and/or processes
Author/year Outcome measures Significant
improvement
+ 1/02/0a 3
RAND
QI-MQCS
score
QI methods QI focus
Dziuban et al., (1994) [39] Risk adjusted mortality 0a 12 Benchmarking Hospital-specific and physician-specific results
published annually in cardiac surgery.
Adams et al., (1998) [43] Ambulation/locomotion 0 10 No clear QI
method
Implementation of and outcome-based quality
improvement concept including two outcome
reports.Bathing 0
Management of oral
medications
0
Pain 0
Dyspnoea 0
Halpin et al., (2004) [40] Postoperative Atrial
fibrillation
0a 11 Benchmarking Implementation of a new guideline based
on insights into outcomes, literature and
roundtable discussion. An Outcome Center
was formed and a multidisciplinary
Performance Improvement Committee.
Operative mortality 0
Cardiac arrest 0
Reoperation for bleeding 0
Pneumonia 0
Deep sternal infection 0
Permanent stroke 0
Transient stroke 0
Prolonged ventilation 0
Length of stay 0
Moller et al., (2005) [38] Overall operative
Mortality
0a 7 Benchmarking Developed a centralized data acquisition and
analysis method (through the creation of the
network paediatric Cardiac Care Consortium).
A uniform diagnostic and procedure
classification system was created. Differences
in patient populations cared for at the cardiac
centres were compared.
Thomas et al., (2007) [24] HgbA1c 0 13 IT application
as feedback tool
Registry-generated audit, feedback and patient
reminder targeted at residents.
LDL cholesterol 0
Blood pressure 0
Peterson et al., (2008) [27] Mean systolic blood
pressure
+ 10 IT application
as feedback tool
Multicomponent intervention: implementation
of an electronic diabetes registry, visit
reminders, and patient-specific physician alerts.
HbA1c +
Mean LDL +
Carlhed et al., (2009) [42] Mortality + 12 Collaborative
Care Model
Multidisciplinary teams consisted of critical
care unit nurses and cardiologists were
assigned at each of the 19 volunteering
hospitals. 19 teams of 4 to 5 persons met at
4 (group A) or 2 (group B) training sessions
during which education by QI experts was
provided, using the Breakthrough Series
curricula.
Readmission rate +
Bleeding complication +
Jakobsen et al., (2009) [33] 1-year survival + 5 Benchmarking Indicators (staging, surgical procedures,
complications and survival) have been
registered in 5007 patients who underwent
surgery. Each year the results have been
audited locally, regionally and nationally and
improvements have been proposed,
implemented, monitored and evaluated by
the audit-plenary.
2-year survival +
5-year survival 0
30-day mortality 0a
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Table 2 Improvement in outcomes and/or processes (Continued)
Author/year Outcome measures Significant
improvement
+ 1/02/0a 3
RAND
QI-MQCS
score
QI methods QI focus
Kraynack et al., (2009) [35] FEV1 0a 12 Learning and
Leadership
Collaborative
A QI process is described from the initial
team-building phase, through the assessment
of care processes, standardization of care,
and developing a culture of continuous
improvement aiming to improve pulmonary
function of the paediatric patients.
MacLean et al., (2009) [25] Blood pressure 0 10 The Chronic
Care Model
Providing decision support and patient
decision support in diabetes care delivery.
BMI 0
SF-12
Physical
0a
SF-12 Mental
Quality of life
0
Exercise habit +
Toh et al., (2009) [30] Poor HbA1c
(9% and above)
0a 11 IT application
as feedback tool
Chronic disease management system with
patient reminders based on registry data.
Good LDL-control
below 2.6 mmol/L
0a
Baty et al., (2010) [29] % with HbA1c < 7% + 10 No clear QI
method
Implementing a comprehensive system-based
disease management process including a
diabetes registry and quality reports.% with HbA1c < 9% +
%with LDL < 100 +
Beaulieau et al., (2010) [41] Mortality 0a 7 Benchmarking
IT application
as feedback tool
Implementing a method for linking
administrative and registry data to track
quality improvement initiatives through
dashboards.
Infusion rate 0a
Bricker et al., (2010) [28] A1C 0a 9 Collaborative
Care Model
Implementing the Chronic Care Model
through regional care learning collaborative
with focus on team-based care,
patient-centred care coordination, delivery of
evidence-based care, patient self-management,
use of a patient registry system and culturally
and linguistically competent care.
Blood pressure 0a
LDL Cholesterol levels 0a
Bauer et al. (2011) [44] Depression improved
in acute phase
(PHQ-9 score)
+ 12 Collaborative
Care Model
Implementing a collaborative care model
including a web-based disease registry,
care management to support treatment
and organized psychiatric consultation.
A1C testing 0 10 Plan-do-check-act
(PDCA)
Realizing continuous quality improvement
through benchmarking in cystic fibrosis care.
Stern et al., (2011) [36] FEV1 > 80 < 18 0a
FEV1 > 80 > 18 0a
BMI > 19 0a
WH > 90 0a
Jakobsen et al., (2013) [34] 1-year survival + 5 Benchmarking Indicators were established, validated, and
monitored. 40,000 patients have been included
in the database. Results were reported
periodically and submitted to realize auditing
on an annual basis.
2-year survival +
5-year survival +
Siracusaet al., (2014) [37] Median FEV1 0a 13 Plan-do-check-act
(PDCA)
The Chronic
Care Model
Several improvement interventions
implemented between 2001 and 2007 with
focus on patient and family engagement in
CF care, improve access and use of data,
individualized scheduling, improving
vaccination rates, infection control aiway
clearance, standardization of care processes,
and forming and QI team.
Median body mass
index (BMI)
0a
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diseases [25]. The second study applied the CCM in
children with various chronic conditions, in combination
with PDCA cycles, failure mode and effect analysis and
Pareto charts of failures [32]. This study resulted in
improvement of respective outcomes [32]. The third
study applied the CCM to ensure that all aspects of cys-
tic fibrosis management were covered, and combined
this with the PDCA to continually evaluate the processes
of best practices in cystic fibrosis care. They did not
evaluate the effectiveness of applying the CCM.
Table 2 Improvement in outcomes and/or processes (Continued)
Author/year Outcome measures Significant
improvement
+ 1/02/0a 3
RAND
QI-MQCS
score
QI methods QI focus
Peterson et al., (2015) [26] Systolic blood
pressure
0a 13 Plan-do-check-act
(PDCA)
Collaborative
Care Model
The effect of 23 diabetes teams joining a
quality collaborative on patient outcomes.
HbA1c 0a
LDL 0a
Han et al. (2016) [31] Hospitalization
with ambulatory
care-sensitive
conditions
+ 7 No clear
QI method
Using clinical registry data to identify patients
who should receive reminders for
preventive/follow-up care and send
reminders to those patients. Generate a list
of patients by condition to use for quality
improvement.ED visits +
Lail et al., (2017) [32] Disease remission 0a 13 The Chronic
Care Model
Eighteen condition teams implemented
interventions varying from: establishing
pre-visit planning (PVP), identifying the target
populations, selecting and measuring
outcomes and supporting processes, building
and implementing care coordination, and
assessing and addressing self-management
support. The teams were free to choose
the interventions that they thought would
work best.
Disease control 0a
Quality of life 0a
Symptom management 0a
1+ means that the result was statistically significant at a p-value of 0.05
20 means that there was no significant improvement in outcomes
30a means that there was improvement, but significance was not tested or reported
Table 3 Scoring of the RAND QI-MQCS
Dziuban
et al.,
(1994) [39]
Adams
et al.
(1998) [43]
Halpin
et al.
(2004) [40]
Moller
et al.,
(2005) [38]
Thomas
et al.,
(2007) [24]
Carlhed
et al.,
(2009) [42]
Peterson
et al.,
(2008) [27]
Jakobsen
et al.,
(2009) [33]
MacLean
et al.,
(2009) [25]
Kraynack &
MacBride
(2009) [35]
1. Organizational motivation Y Y Y N Y Y N N N N
2. Intervention rationale Y Y Y Y Y Y Y N Y Y
3 Intervention description Y N Y Y Y Y Y N Y Y
4. Organizational characteristics Y Y Y N N Y N N Y Y
5. Implementation Y N Y Y Y Y Y N Y Y
6. Study design Y Y N N Y Y Y Y Y Y
7. Comparator Y N Y N Y Y Y N Y Y
8. Data source Y Y Y Y Y Y Y Y Y Y
9. Timing Y Y Y N Y Y Y N Y Y
10. Adherence and fidelity N N Y N N N N N N Y
11. Health outcomes Y Y Y Y Y Y Y Y Y Y
12. Organizational readiness Y N Y N Y N N N N Y
13. Penetration and reach N N N N N Y Y Y Y N
14. Sustainability N Y N Y Y N N N N N
15. Spread N Y N Y Y N N N N Y
16. Limitations Y Y N N Y Y Y Y N N
Total score (Y) 12 10 11 7 13 12 10 5 10 12
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Learning and leadership collaborative
The Learning and Leadership Collaborative (LLC) was
applied in one study [35]. Commitment of a team to par-
ticipate in a QI program, developing a sense of common
responsibility as an organization for the improvement,
measuring outcomes and processes and patient involve-
ment were defined as key ingredients for QI. LLC has
been used for training staff towards structured discus-
sions on outcomes and/or processes and the introduc-
tion of a patient registry [35]. Data was registered and
analyzed at one particular hospital, but presented to all
participating hospitals. Participation in the LLC has led
to the initiation of an improvement initiative at the hos-
pital where the data were registered and analyzed.
IT application as feedback tool
Five studies made used of (self-developed) IT applica-
tions, to empower patients and/or physicians to man-
age patients with greater care. The studies aimed at
linking administrative and key clinical data and made
use of reminder functions [24, 27, 30]. One study con-
cluded their patients received better overall coordin-
ation of care [30]. Another two studies reported
significant improvements in the percentage of type 2
diabetic patients and at-risk populations utilizing dia-
betes registries achieving recommended values for SBP,
LDL, and HbA1C [27]. In one study, data were in
addition displayed in operating room theatre, surgical
office suites and nursing units [41]. Another study
reported improved adherence to diabetes care processes
in a continuity clinic due to the registry-generated
audit, feedback, and patient reminders [24].
Facilitators for quality improvements
A noticeable facilitator leading to QI was frequent
reporting and feedback either annually or even monthly
[28, 33, 34, 38–41]. The use of a database with high
quality data, audits and reports as well as a strong stake-
holder involvement were also found to be important fac-
tors contributing to successful QI [33, 34]. Structured
registry data and an improvement intervention that can
be linked to outcomes led to improvement in respective
outcome measures [42]. In addition, other factors men-
tioned that would be needed for successful QI in one or
more of the included studies are (1) patient involvement,
communication, and standardization; (2) attitude and enthu-
siastic commitment from physicians, clinical managers and
central administration and (3) appreciation concerning the
importance of measurements [28, 35, 40, 41]. Moreover,
improvement in outcomes appeared to be successful if
supported by a proven QI approach [42]. Inconsistencies
were found regarding the importance of involving an expert
in the field of QI. On the one hand, involvement of a QI
expert was considered positive for the start of an
improvement agenda as it contributed to a more rapid im-
plementation of improvement initiatives [42]. On the other
hand, involving no additional expert or formal team was not
experienced as a contributing factor to the success of out-
come improvement [26]. This was only possible because a
structured data registry was already present [26].
Catalyst to improve outcomes over time
Outcomes can be improved over time through system-
atic use of outcome registries and facilitators. Outcome
data and its interpretation help to achieve improvements
in outcomes over time even faster compared to studies
that did not use outcome data [34]. It was stated that
outcomes were not only used to identify possible im-
provement interventions but also to monitor and secure
improvements in the long run [34].
A computerized system was presented as a success
factor to accelerate data from clinical registries to
change outcomes and/or processes [26–29, 31–36, 42,
45]. Such a computerized system ensured valid and
timely results [33]. Moreover, it allows for real-time
feedback, which, in turn, leads to faster identification of
improvement areas [28, 29, 31, 42].
Further use of outcome data for outcome improve-
ment included the development of checklists, im-
proved use of diagnostic standards, creation of data
transparency, guidelines, improved patient recall, pa-
tient empowerment and leadership towards improve-
ment [28, 29, 31, 36].
Discussion
Eight out of the 21 included studies reported statistically
significant improvements in outcomes including long-
term survival, mortality, readmission rate, bleeding
complications, systolic blood pressure, HbA1C, LDL,
exercise habits (FEV1), depression improved in the acute
phase (PHQ-9 score) and hospitalization with ambulatory
care-sensitive conditions resulting from the implementa-
tion of QI initiatives. Out of these eight studies, the
Chronic Care Model, IT application as feedback, bench-
marking and the Collaborative Care Model were used as
QI methods. A diverse set of clinical outcomes were
collected and no patient-reported outcome measures
(PROMs) were applied in any of the studies. Yet, only one
study that reported statistically significant improvements
in outcomes was of good quality. The improvement
interventions were diverse, ranging from the imple-
mentation of guidelines, development of physician/pa-
tient alerts, improved teamwork, patient engagement
methods through IT applications and the development
of a supportive decision system. Many improvement inter-
ventions were combined in order to build a multifaceted
approach to QI [24, 27, 28, 32, 37, 42, 44]. Facilitators for
realizing QI include a high quality database, the use of
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pre-defined outcome measures, audits, frequent reporting
and feedback, patient involvement, improved communica-
tion and standardization. Systematic approaches were
used for structuring the improvement cycle. In order to
use data from clinical registries as a catalyst to change out-
comes, this review suggests that having a strong comput-
erized system is supportive in aiding frontline clinical
process management and improvement work.
A facilitator identified in this review was the organization
of discussions for mapping and selecting best practices. It
was further shown that a sound data management has a
catalyzing effect. This data can be aggregated in annual re-
ports, while it can also be used to compare with peers and/
or perform nationwide comparisons. Also, a registry can fa-
cilitate access to real-time outcome and process data which
can engage the team in realizing active improvements.
Other registry programs such as the Get With The
Guidelines-Stroke study, a large registry and performance
improvement program for hospitalized patients with stroke
and transient ischemic attack, also use annual reports for
benchmark and feedback purposes [46].
Other systematic reviews concluded that audit and feed-
back can lead to small but important improvements in
professional practice and healthcare outcomes [47]. They
furthermore concluded that the effectiveness of audit and
feedback depends on how the feedback was provided as well
as on baseline performance. In addition, comparing this
review to ours, there was one paper we have both included
[24]. However, the objectives are very different, which can
explain that there was not more overlap in included studies.
In addition, barriers and success factors to the effective-
ness of feedback have been identified [48]. However, the
authors were not able to draw sound conclusions on the
effect of feedback on the quality of care and its potential
to improve outcomes. Another review concerning renal
registry data reflected on the potential of registry data and
help advancing the nephrology care delivery [49].
None of the reviews studied the effect of QI efforts,
besides from audit and feedback, on the quality of care
and outcomes. This is the first study for which the litera-
ture was searched in detail in order to identify barriers
and facilitators supporting QI interventions based on
information from clinical registries.
The use of clinical registries can be seen as an import-
ant tool in order to systematically measure clinical out-
comes and to achieve the goals of value-based health
care. This is not only in line with our conclusions, but
also acknowledged by others [1, 50, 51]. Other data
sources can also be valuable for QI efforts, such as data
from randomized controlled trials. However, this review
aimed at including studies where structural data was
collected through the use of a clinical registry.
In order to improve value, measuring both one or
more outcomes and costs is essential [17]. Working with
international registries makes it possible to make global
comparisons, for example identifying practice variations
and therefore improving quality of care for the whole
patient group [52].
Implications
We did not observe many efforts to incorporate PROMs.
It is, however, generally considered important to meas-
ure the impact on health related quality of life (HRQoL)
in the evaluation of the effect of QI initiatives [53]. The
studies included for this review did not reflect on why
they did not use PROMs and what would be the added
value if they did. Even so, one study does report however
the start of measuring quality of life in patients with cys-
tic fibrosis [36]. The authors report this will lead to
more insights into the complexity of QI efforts and per-
sonal patient gains in the experienced quality of life. It
will also enable reporting on to what extent value was
created from the patient’s perspective. Future QI efforts
very likely combine QI with benchmarking incorporating
quality of life outcomes.
None of the included studies reported costs, causing
our study to be unable to evaluate the true impact on
value. Incorporating costs will enable to identify cost
drivers and comparing improvement interventions as
proposed by the value-based healthcare principles [50].
A recent study showed that surgery for the oldest pa-
tients with colorectal cancer did not lead to increased
hospital costs [51]. However, this study did identify
variation in cost driver distribution. Patients under 85
years old had lower costs looking at the ward, operation
and intensive care unit. Therefore, identifying costs and
its main drivers will enable to develop improvement
programs for specific sub-groups. This might be a
powerful tool to reduce e.g. complications and thus
hospital costs. Value-based health care could be the
overarching concept guiding improvement initiatives,
combined with well-defined methods. However, the
field lacks a clear guide on implementation examples.
Studies reflecting on impact, outcomes and costs are
needed. Finally, the standardization of outcome mea-
sures is key, although they should be defined for a spe-
cific patient population. Transparent measurement of
outcomes and costs has the potential to improving the
value of care for all patients. Both providers, patients
and payers can benefit from this collective common
goal of transparency.
Limitations
This review has some inherent limitations. Firstly, due to
the very heterogeneous types of QI programs and their
respective patient groups, it is difficult to generalize the
results achieved in the included studies. Moreover, our
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inclusion criteria for QI programs may be to some ex-
tent arbitrary, which could possible lead to a bias in
inclusion or exclusion of studies.
Also, the context in which the clinical registry is orga-
nized can impact outcomes. Moreover, important differ-
ences were observed in e.g. whether the registry was
linked to reimbursement or public reporting versus
primarily initiated for scientific or QI purposes or whether
it was a voluntary or mandatory registry.
Secondly, the studies included in this review mainly
focused on experiences in non-communicable diseases
and thus often chronic patient groups. However, our aim
was not to exclude communicable diseases from the
study but we did not identify any studies in our litera-
ture search. This could indicate that chronic patient
groups benefitted most from the realization of registries
and respective QI interventions. As a result, improve-
ment projects concerning other (non-chronic) patient
groups have not been included in this review. Thirdly,
due to publication bias, studies reporting no effect
will be very likely not published and therefore missed
out. Finally, two studies randomized practices [25,
27]. One study randomly allocated 19 volunteering
hospitals to 1 of 2 intervention groups, where the
intervention differed both in design and intensity
[42]. In the other studies it should be noted that
complete randomization was not possible, since the
intervention hospitals involved were e.g. volunteering.
Therefore, these hospitals might differ in their will-
ingness to improve, causing potential selection bias.
Conclusion
The results from this evaluation of studies which use
outcome measures from clinical registry data to im-
plement and monitor QI initiatives may help policy
makers, managers and clinicians to understand the
effectiveness, practicality and challenges of imple-
menting QI interventions. An active and systematic
approach is needed to improve outcomes. Continuous
feedback from the data linked to clinical practice is
crucial. Our review indicates that successful QI and
consequently improved outcomes, is dependent on an
active approach and organizational readiness.
There are many QI methods, and the majority of
improvement interventions contain a combination of
several methods. Clinical registries can be seen as sup-
portive instruments in the process of improving quality
of care. However, a clinical registry can only be success-
ful in realizing QI efforts when there is commitment and
leadership at both the physician and manager level, as
well as a benchmarking facility, a well-integrated com-
puterized system, and a collective aim to identify best
practices.
Additional files
Additional file 1: Appendix 1. Caption: Search string PubMed, Embase
and Cochrane. Appendix 2. Caption: Eligibility Form Data collection form
for intervention reviews: RCTs and non-RCTs. Appendix 3. Caption: Quality
Improvement Minimum Quality Criteria Set (QI-MQCS) items. From: Hempel,
Susanne, Paul G. Shekelle, Jodi L. Liu, Margie Sherwood Danz, Robbie Foy,
Yee-Wei Lim, Aneesa Motala, and Lisa V. Rubenstein. Development of the
Quality Improvement Minimum Quality Criteria Set (QI-MQCS): a tool
for critical appraisal of quality improvement intervention publications.
BMJ quality & safety (2015): bmjqs-2014. Appendix 4. Caption: Detailed
Summary of Included Studies. Appendix 5. Caption: Scoring of the Downs &
Black criteria, SQUIRE guidelines and additional self-developed tool. Notes: a
From the Downs & Black questionnaire, question 2 and 18 have been used
(Downs & Black 1998). b From the SQUIRE guidelines, question 10c,11a and
11b have been used (Ogrinc et al., 2008). (DOCX 101 kb)
Abbreviations
BCM: the Breakthrough Collaborative Model; CCM: Chronic Care Model;
FEV1: Forced expiratory volume in one second; HbA1C: Glycated
Hemoglobin; HRQoL: Health related quality of life; LDL: Low-density
lipoprotein; LLC: Learning and Leadership Collaborative; PDCA: Plan-Do-
Check-Act; PROMs: Patient-reported outcome measures; QI: Quality
Improvement; QI-MQSC: Quality Improvement Minimum Quality Criteria Set;
SQUIRE: Standards for Quality Improvement Reporting Excellence
Acknowledgements
We thank Carla Sloof for her support in formulating the search strategy, the
English language professional Valesca Hulsman for editing, and Jozé
Braspenning who performed a critical review of the manuscript.
Funding
This study was supported by The Netherlands Organisation for Health
Research and Development (ZonMw) under project number 842001005. The
funder had no influence on the study design, collection, analysis and
interpretation of the data, the writing of the report, and the decision in
where to submit the article for publication.
Availability of data and materials
Not applicable.
Authors’ contributions
NK, NZ, PvdN, PvdW, SG and GW (hereinafter referred to as ‘all authors’)
contributed to the conception and design of the study. The first two
authors, NK and NZ, shared equally in the development and execution of
the work. NK and NZ were the major contributors in writing the manuscript.
NK, NZ, PvdN, PvdW, SG analyzed and interpreted the data. NK, NZ, PvdN,
PvdW, SG had full access to all data in the study and take responsibility for
the integrity of the data and accuracy of the data analysis. All authors
contributed to the analysis and interpretation, and provided drafting of the
article. All authors contributed to the revision of the article for important
intellectual content. All authors read and approved the final manuscript.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Kampstra et al. BMC Health Services Research         (2018) 18:1005 Page 12 of 14
Received: 29 June 2018 Accepted: 17 December 2018
References
1. Larsson S, Lawyer P. Improving health care value - the case for disease
registries; 2011.
2. Gliklich RE, Dreyer NA, Leavy MB. Registries for evaluating patient outcomes:
a user’s guide. Rockville (MD): Government Printing Office; 2014.
3. Gitt AK, Bueno H, Danchin N, Fox K, Hochadel M, Kearney P, Maggioni AP,
Opolski G, Seabra-Gomes R, Weidinger F. The role of cardiac registries in
evidence-based medicine. Eur Heart J. 2010;31(5):525–9.
4. Hickey GL, Grant SW, Cosgriff R, Dimarakis I, Pagano D, Kappetein AP,
Bridgewater B. Clinical registries: governance, management, analysis and
applications. Eur J Cardiothorac Surg. 2013;44(4):605–14.
5. Black N. High-quality clinical databases: breaking down barriers. Lancet.
1999;353(9160):1205–6.
6. Pryor DB, Califf RM, Harrell FE, Hlatky MA, Lee KL, Mark DB, Rosati RA. Clinical
data bases: accomplishments and unrealized potential. Med Care. 1985;
23(5):623–47.
7. Aljurf M, Rizzo J, Mohty M, Hussain F, Madrigal A, Pasquini M, Passweg J,
Chaudhri N, Ghavamzadeh A, Solh H. Challenges and opportunities for
HSCT outcome registries: perspective from international HSCT registries
experts. Bone Marrow Transplant. 2014;49(8)1016–21.
8. Bhatt DL, Drozda JP, Shahian DM, Chan PS, Fonarow GC, Heidenreich PA,
Jacobs JP, Masoudi FA, Peterson ED, Welke KF. ACC/AHA/STS statement on
the future of registries and the performance measurement Enterprise: a
report of the American College of Cardiology/American Heart Association
task force on performance measures and the Society of Thoracic Surgeons.
J Am Coll Cardiol. 2015;66(20):2230–45.
9. Evans SM, Scott IA, Johnson NP, Cameron PA, McNeil JJ. Development of
clinical-quality registries in Australia: the way forward. Med J Aust. 2011;
194(7):360–3.
10. McNeil JJ, Evans SM, Johnson NP, Cameron PA. Clinical-quality registries:
their role in quality improvement. Med J Aust. 2010;192(5):244–5.
11. Stey AM, Russell MM, Ko CY, Sacks GD, Dawes AJ, Gibbons MM. Clinical
registries and quality measurement in surgery: a systematic review. Surgery.
2015;157(2):381–95.
12. Porter ME. Value-based health care delivery. Ann Surg. 2008;248(4):503–9.
13. Porter ME. What is value in health care? N Engl J Med. 2010;363(26):2477–248.
14. Erekson EA, Iglesia CB. Improving patient outcomes in gynecology: the role
of large data registries and big data analytics. J Minim Invasive Gynecol.
2015;22(7):1124–9.
15. Donabedian A. Evaluating the quality of medical care. Milbank Q. 2005;83(4):
691–729.
16. Hedges LV, Vevea JL. Fixed-and random-effects models in meta-analysis.
Psychol Methods. 1998;3(4):486.
17. Porter ME, Pabo EA, Lee TH. Redesigning primary care: a strategic vision to
improve value by organizing around patients' needs. Health Aff (Millwood).
2013;32(3):516–25.
18. Cochrane Training. Data collection forms for intervention reviews. https://
dplp.cochrane.org/data-extraction-forms. Accessed 2 Mar 2017.
19. Hempel S, Shekelle PG, Liu JL, Sherwood Danz M, Foy R, Lim YW, Motala A,
Rubenstein LV. Development of the quality improvement minimum quality
criteria set (QI-MQCS): a tool for critical appraisal of quality improvement
intervention publications. BMJ Qual Saf. 2015;24(12):796–804.
20. Downs SH, Black N. The feasibility of creating a checklist for the assessment of
the methodological quality both of randomised and non-randomised studies
of health care interventions. J Epidemiol Community Health. 1998;52(6):377–84.
21. Ogrinc G, Mooney SE, Estrada C, Foster T, Goldmann D, Hall LW, Huizinga
MM, Liu SK, Mills P, Neily J, Nelson W, Pronovost PJ, Provost L, Rubenstein
LV, Speroff T, Splaine M, Thomson R, Tomolo AM, Watts B. The SQUIRE
(standards for QUality improvement reporting excellence) guidelines for
quality improvement reporting: explanation and elaboration. Qual Saf
Health Care. 2008;17(Suppl 1):i13–32.
22. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for
systematic reviews and meta-analyses: the PRISMA statement. Ann Intern
Med. 2009;151(4):264–9.
23. Hoque DME, Kumari V, Hoque M, Ruseckaite R, Romero L, Evans SM. Impact
of clinical registries on quality of patient care and clinical outcomes: a
systematic review. PLoS One. 2017;12(9):e0183667.
24. Thomas KG, Thomas MR, Stroebel RJ, McDonald FS, Hanson GJ, Naessens
JM, Huschka TR, Kolars JC. Use of a registry-generated audit, feedback, and
patient reminder intervention in an internal medicine resident clinic—a
randomized trial. J Gen Intern Med. 2007;22(12):1740–4.
25. MacLean CD, Gagnon M, Callas P, Littenberg B. The Vermont diabetes
information system: a cluster randomized trial of a population based
decision support system. J General Intern Med. 2009;24(12):1303–10.
26. Peterson A, Gudbjornsdottir S, Lofgren UB, Schioler L, Bojestig M, Thor J,
Andersson Gare B. Collaboratively improving diabetes Care in Sweden
Using a National Quality Register: successes and challenges-a case study.
Qual Manag Health Care. 2015;24(4):212–21.
27. Peterson KA, Radosevich DM, O'Connor PJ, Nyman JA, Prineas RJ, Smith SA,
Arneson TJ, Corbett VA, Weinhandl JC, Lange CJ, Hannan PJ. Improving
diabetes Care in Practice: findings from the TRANSLATE trial. Diabetes Care.
2008;31(12):2238–43.
28. Bricker PL, Baron RJ, Scheirer JJ, DeWalt DA, Derrickson J, Yunghans S, Gabbay
RA. Collaboration in Pennsylvania: rapidly spreading improved chronic care for
patients to practices. J Contin Educ Heal Prof. 2010;30(2):114–25.
29. Baty PJ, Viviano SK, Schiller MR, Wendling AL. A systematic approach to
diabetes mellitus care in underserved populations: improving care of
minority and homeless persons. Fam Med. 2010;42(9):623–7.
30. Toh MP, Leong HS, Lim BK. Development of a diabetes registry to improve
quality of care in the National Healthcare Group in Singapore. Ann Acad
Med Singap. 2009;38(6):546.
31. Han W, Sharman R, Heider A, Maloney N, Yang M, Singh R. Impact of
electronic diabetes registry 'meaningful use' on quality of care and hospital
utilization. J Am Med Informatics Assoc. 2016;23(2):242–7.
32. Lail J, Schoettker PJ, White DL, Mehta B, Kotagal UR. Applying the chronic
care model to improve care and outcomes at a pediatric medical center. Jt
Comm J Qual Patient Saf. 2017;43(3):101–12.
33. Jakobsen E, Palshof T, Osterlind K, Pilegaard H. Data from a national lung
cancer registry contributes to improve outcome and quality of surgery:
Danish results. Eur J Cardiothorac Surg. 2009;35(2):348–52 discussion 352.
34. Jakobsen E, Green A, Oesterlind K, Rasmussen TR, Iachina M, Palshof T.
Nationwide quality improvement in lung cancer care: the role of the Danish
lung Cancer group and registry. J Thorac Oncol. 2013;8(10):1238–47.
35. Kraynack NC, McBride JT. Improving care at cystic fibrosis centers through
quality improvement. Semin Respir Crit Care Med. 2009;30:547–58.
36. Stern M, Niemann N, Wiedemann B, Wenzlaff P, German CFQA Group.
Benchmarking improves quality in cystic fibrosis care: a pilot project
involving 12 centres. Int J Qual Health Care. 2011;23(3):349–56.
37. Siracusa CM, Weiland JL, Acton JD, Chima AK, Chini BA, Hoberman AJ,
Wetzel JD, Amin RS, McPhail GL. The impact of transforming healthcare
delivery on cystic fibrosis outcomes: a decade of quality improvement at
Cincinnati Children's Hospital. BMJ Qual Saf. 2014;23(Suppl 1):i56–63.
38. Moller JH, Hills CB, Pyles LA. A multi-center cardiac registry. A method to
assess outcome of catheterization intervention or surgery. Prog Pediatr
Cardiol. 2005;20(1):7–12.
39. Dziuban SW, McIlduff JB, Miller SJ, Dal Col RH. How a New York cardiac
surgery program uses outcomes data. Ann Thorac Surg. 1994;58(6):1871–6.
40. Halpin LS, Barnett SD, Burton NA. National databases and clinical practice
specialist: decreasing postoperative atrial fibrillation following cardiac
surgery. Outcomes Manag. 2004;8(1):33–8.
41. Beaulieu PA, Higgins JH, Dacey LJ, Nugent WC, DeFoe GR, Likosky DS.
Transforming administrative data into real-time information in the
Department of Surgery. Qual Saf Health Care. 2010;19(5):399–404.
42. Carlhed R, Bojestig M, Peterson A, Aberg C, Garmo H, Lindahl B, Quality
Improvement in Coronary Care Study Group. Improved clinical outcome after
acute myocardial infarction in hospitals participating in a Swedish quality
improvement initiative. Circ Cardiovasc Qual Outcomes. 2009;2(5):458–64.
43. Adams CE, Wilson M, Haney M, Short R. Using the outcome-based quality
improvement model and OASIS to improve HMO patients' outcomes. Outcome
assessment and information set. Home Healthc Nurse. 1998;16(6):395–401.
44. Bauer AM, Azzone V, Goldman HH, Alexander L, Unützer J, Coleman-Beattie
B, Frank RG. Implementation of collaborative depression management at
community-based primary care clinics: an evaluation. Psychiatr Serv. 2011;
62(9):1047–53.
45. Lee TH, Pearson SD, Johnson PA, Garcia TB, Weisberg MC, Guadagnoli E,
Cook EF, Goldman L. Failure of information as an intervention to modify
clinical management: a time-series trial in patients with acute chest pain.
Ann Intern Med. 1995;122(6):434–7.
Kampstra et al. BMC Health Services Research         (2018) 18:1005 Page 13 of 14
46. Fonarow GC, Reeves MJ, Smith EE, Saver JL, Zhao X, Olson DW, Hernandez
AF, Peterson ED, Schwamm LH, GWTG-Stroke Steering Committee and
Investigators. Characteristics, performance measures, and in-hospital
outcomes of the first one million stroke and transient ischemic attack
admissions in get with the guidelines-stroke. Circ Cardiovasc Qual
Outcomes. 2010;3(3):291–302.
47. Ivers N, Jamtvedt G, Flottorp S, Young JM, Odgaard-Jensen J, French SD,
O’Brien MA, Johansen M, Grimshaw J, Oxman AD. Audit and feedback: effects
on professional practice and healthcare outcomes. Cochrane Database Syst
Rev Reviews 2012, Issue 6. Art. No.: CD000259. p 1–229.
48. van der Veer SN, de Keizer NF, Ravelli ACJ, Tenkink S, Jager KJ.
Improving quality of care. A systematic review on how medical
registries provide information feedback to health care providers. Int J
Med Inform. 2010;79(5):305–23.
49. Lim T, Goh A, Lim Y, Morad Z. Use of renal registry data for research, health-
care planning and quality improvement: what can we learn from registry
data in the Asia–Pacific region? Nephrology. 2008;13(8):745–52.
50. Porter ME, Lee TH. The strategy that will fix health care. Harv Bus Rev. 2013;
91(12):24.
51. Govaert JA, Govaert MJ, Fiocco M, van Dijk WA, Tollenaar RA, Wouters MW.
Hospital costs of colorectal cancer surgery for the oldest old: a Dutch
population-based study. J Surg Oncol. 2016;114(8):1009–15.
52. McNamara RL, Spatz ES, Kelley TA, Stowell CJ, Beltrame J, Heidenreich P,
Tresserras R, Jernberg T, Chua T, Morgan L, Panigrahi B, Rosas Ruiz A,
Rumsfeld JS, Sadwin L, Schoeberl M, Shahian D, Weston C, Yeh R, Lewin J.
Standardized Outcome Measurement for Patients With Coronary Artery
Disease: Consensus From the International Consortium for Health Outcomes
Measurement (ICHOM). J Am Heart Assoc. 2015;4(5). https://doi.org/10.1161/
JAHA.115.001767.
53. Porter ME, Larsson S, Lee TH. Standardizing patient outcomes measurement.
N Engl J Med. 2016;374(6):504–6.
Kampstra et al. BMC Health Services Research         (2018) 18:1005 Page 14 of 14
